Companies

Biocartis is a Mechelen-based molecular diagnostics company whose Idylla platform delivers oncology biomarker results in about three hours.

THERAtRAME discovers and develops small molecules targeting tRNA epitranscriptomics to treat cancer patients with immune-refractory and resistant tumors.

Celyad Oncology is a Belgian biotechnology company focused on developing next-generation CAR T-cell therapies.